Setting the Stage for the Next 10 Years of Health Care Payment Innovation

This Viewpoint describes 4 health policy strategies that could help lead to improvements in cost and quality in the US health care system.

6d

Adolescent Myocarditis After COVID-19 Vaccination Rare

Postmarketing safety monitoring data suggest that nonserious local and systemic reactions are common among adolescents who receive a SARS-CoV-2 mRNA vaccine, while reports of severe adverse events like myocarditis are rare.

6d

SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination

In a recent study, binding and functional antibodies against SARS-CoV-2 variants persisted for at least 6 months for most adults who received both doses of Moderna’s mRNA vaccine. However, the antibodies waned over that period and some serum samples collected at 6 months no longer neutralized the variants, the researchers reported in Science.

6d

Taxonomy of the Oaks

I push my father’s chair Around the home Streets named “Halcyon” and “Reminiscence” He spots a squirrel on a tree and grunts

6d

Point-of-Care SARS-CoV-2 Variant Diagnostic in Development

Researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering recently described a low-cost, user-friendly point-of-care (POC) device that detects SARS-CoV-2 and several variants of concern in an hour using saliva samples.

6d

After Mildest Flu Season Ever, Influenza Experts Wonder What Comes Next

This Medical News feature examines potential scenarios about how severe the upcoming flu season might be, given the dearth of influenza worldwide since the COVID-19 pandemic began.

6d

Percentage Incorrect in 2 Places

In the Original Investigation titled “Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes,” published in the May 25, 2021, issue of JAMA, an incorrect percentage appeared in the abstract and in the text. In the Results section of the abstract, the first sentence should have been “Of 88 159 infants (49.0% girls), 2323 (2.6%)...

6d

Potential New Immune-Checkpoint Inhibitor Partner for Lung Cancer

There could be a new way to boost the response to immune-checkpoint inhibitors for patients with metastatic non–small cell lung cancer.

6d

Screening for Chlamydia and Gonorrhea

The first large randomized clinical trial (RCT) to study the effect of screening asymptomatic women for Chlamydia trachomatis infection was conducted in the early 1990s in a managed care organization in the US Pacific Northwest. The investigators measured the incidence of symptomatic pelvic inflammatory disease (PID) diagnosed in clinic or hospital...

6d

USPSTF Review: Screening for Chlamydial and Gonococcal Infections

This systematic review to support the 2021 US Preventive Services Task Force Recommendation Statement on screening for chlamydial and gonococcal infections summarizes published evidence on the benefits and harms of screening for chlamydial and gonococcal infection in adults and adolescents, including those who are pregnant.

6d